Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M James Phillips

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Plos One|October 23, 2013
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WERamzi Khattar, Olga Luft, Nataliya Yavorska, et al.
Lancet (London, England)|October 11, 2003
Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhoodM James Phillips, Toshifumi Azuma, Sheue-Lim M Meredith, et al.
Immunology|July 4, 2014
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allograftsPeter Urbanellis, Wendy Shyu, Ramzi Khattar, et al.
Physiological Genomics|June 7, 2007
Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in miceJunwu Mu, Dawei Qu, Agata Bartczak, et al.
Transplantation|July 23, 2002
Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serumAnand Ghanekar, Ginette Lajoie, Yigang Luo, et al.
Circulation|July 7, 2005
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenograftsMichael Mendicino, MingFeng Liu, Anand Ghanekar, et al.
Transplantation|January 25, 2003
Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGALRobert Zhong, Yigang Luo, Hongji Yang, et al.
Journal of Virology|October 17, 2006
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J miceNadine De Albuquerque, Ehtesham Baig, Xuezhong Ma, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activityGary A Levy, Gord Adamson, M James Phillips, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitisItay Shalev, Kit Man Wong, Katharina Foerster, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Plos One|October 23, 2013
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WERamzi Khattar, Olga Luft, Nataliya Yavorska, et al.
Lancet (London, England)|October 11, 2003
Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhoodM James Phillips, Toshifumi Azuma, Sheue-Lim M Meredith, et al.
Immunology|July 4, 2014
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allograftsPeter Urbanellis, Wendy Shyu, Ramzi Khattar, et al.
Physiological Genomics|June 7, 2007
Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in miceJunwu Mu, Dawei Qu, Agata Bartczak, et al.
Transplantation|July 23, 2002
Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serumAnand Ghanekar, Ginette Lajoie, Yigang Luo, et al.
Circulation|July 7, 2005
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenograftsMichael Mendicino, MingFeng Liu, Anand Ghanekar, et al.
Transplantation|January 25, 2003
Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGALRobert Zhong, Yigang Luo, Hongji Yang, et al.
Journal of Virology|October 17, 2006
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J miceNadine De Albuquerque, Ehtesham Baig, Xuezhong Ma, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activityGary A Levy, Gord Adamson, M James Phillips, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitisItay Shalev, Kit Man Wong, Katharina Foerster, et al.
Pageof 4